ID

13196

Descripción

Copaxone® Study to Follow Patients From the First Original Study for Safety and Effectiveness.; ODM derived from: https://clinicaltrials.gov/show/NCT00203021

Link

https://clinicaltrials.gov/show/NCT00203021

Palabras clave

Versiones (1)
  1. 23/1/16 23/1/16 -
Subido en

23 de enero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Multiple Sclerosis NCT00203021

Inglés

Eligibility Multiple Sclerosis NCT00203021

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients must have participated (been randomized) in the copaxone double-blind placebo controlled study (protocol 01-9001).
Descripción

copaxone study participation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0528175
UMLS CUI [2]
C2348568
gender: patients may be male or female. women of childbearing potential must practice an acceptable method of birth control.
Descripción

Gender, birth control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0700589
patients must meet the criteria of clinically definite ms as defined by poser.5
Descripción

multiple sclerosis diagnosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026769
the patient's signs and symptoms cannot be better explained by another disease process.
Descripción

multiple sclerosis diagnosis

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0026769
patients must sign an approved informed consent prior to initiating the study.
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
patients must be psychologically and physically stable to participate in the trial as judged by the investigator.
Descripción

psychologically and physically stable

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009488
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy or lactation.
Descripción

pregnancy or lactation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
medical or psychiatric conditions that affect the patient's ability to give informed consent or complete the study.
Descripción

nformed consent or study completion limited

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0439801
UMLS CUI [1,3]
C0021430
UMLS CUI [1,4]
C0439801
UMLS CUI [1,5]
C0009488
inability to self-administer subcutaneous medication or lack of another responsible individual to administer the study preparation daily.
Descripción

subcutaneous medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1321605
UMLS CUI [2]
C0021499
use of interferons, experimental ms therapies, or previous immunosuppressive therapy with cytotoxic chemotherapy (azathioprine, cyclophosphamide, or cyclosporine), or total lymphoid irradiation within 30 days of study entry.
Descripción

interferons, experimental ms therapies, immunosuppression or lymphoid irradiation

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021747
UMLS CUI [2,1]
C0021079
UMLS CUI [2,2]
C0392920 | C0024230
Volver a la parte superior de la página

Similar models

Eligibility Multiple Sclerosis NCT00203021

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
copaxone study participation
Item
patients must have participated (been randomized) in the copaxone double-blind placebo controlled study (protocol 01-9001).
boolean
C0528175 (UMLS CUI [1])
C2348568 (UMLS CUI [2])
Gender, birth control
Item
gender: patients may be male or female. women of childbearing potential must practice an acceptable method of birth control.
boolean
C0079399 (UMLS CUI [1])
C0700589 (UMLS CUI [2])
multiple sclerosis diagnosis
Item
patients must meet the criteria of clinically definite ms as defined by poser.5
boolean
C0026769 (UMLS CUI [1])
multiple sclerosis diagnosis
Item
the patient's signs and symptoms cannot be better explained by another disease process.
boolean
C0026769 (UMLS CUI [1])
informed consent
Item
patients must sign an approved informed consent prior to initiating the study.
boolean
C0021430 (UMLS CUI [1])
psychologically and physically stable
Item
patients must be psychologically and physically stable to participate in the trial as judged by the investigator.
boolean
C0009488 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
pregnancy or lactation
Item
pregnancy or lactation.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
nformed consent or study completion limited
Item
medical or psychiatric conditions that affect the patient's ability to give informed consent or complete the study.
boolean
C1321605 (UMLS CUI [1,1])
C0439801 (UMLS CUI [1,2])
C0021430 (UMLS CUI [1,3])
C0439801 (UMLS CUI [1,4])
C0009488 (UMLS CUI [1,5])
subcutaneous medication
Item
inability to self-administer subcutaneous medication or lack of another responsible individual to administer the study preparation daily.
boolean
C1321605 (UMLS CUI [1])
C0021499 (UMLS CUI [2])
interferons, experimental ms therapies, immunosuppression or lymphoid irradiation
Item
use of interferons, experimental ms therapies, or previous immunosuppressive therapy with cytotoxic chemotherapy (azathioprine, cyclophosphamide, or cyclosporine), or total lymphoid irradiation within 30 days of study entry.
boolean
C0021747 (UMLS CUI [1])
C0021079 (UMLS CUI [2,1])
C0392920 | C0024230 (UMLS CUI [2,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial